Supreme Court to Hear Gene-Patent Case


December 3, 2012

On Friday, the U.S. Supreme Court decided to review whether human genes can be patented, reports the Philadelphia Inquirer. The justices agreed to hear a challenge to Myriad Genetics Inc.'s patents on genetic material used in breast and ovarian cancer tests. The University of Pennsylvania's Arupa Ganguly, PhD, professor of Genetics, and Haig Kazazian, MD, former chair of Genetics, are two of the doctors, researchers, and patients who oppose the patents, holding the view that Myriad's monopoly over the genes prevents clinical testing and research. The justices will also hear an appeal from Philadelphia's Mutual Pharmaceutical, maker of the generic anti-inflammatory drug sulindac.

see more at Philadelphia Inquirer article via Bloomberg Businessweek